Press release
Obesity - Pipeline Review, H1 With key players Abeome Corp, Adocia SAS, Aegis Therapeutics LLC, Amgen
Obesity
Get Access to Sample PDF @: https://www.htfmarketreport.com/sample-report/1197577-obesity-pipeline-review-4
If you are want to study the Obesity - Pipeline or intend to be, then this guide will provide you comprehensive outlook. It’s vital for you to keep your knowledge up to date by keeping research and development (R&D) of major players. If you have a different set of players/manufacturers according to geography or needs regional or country segmented reports we can provide requirement according to your needs.
Obesity is defined as having an excessive amount of body fat. Obesity increases risk of diseases and health problems such as heart disease, diabetes and high blood pressure. The predisposing factors include age, family history, quitting smoking, lack of sleep and certain medications. Treatment includes healthy lifestyle, medications and surgery.
Key Players included in the research study are Abeome Corp, Adocia SAS, Aegis Therapeutics LLC, Amgen Inc, Antag Therapeutics ApS, Aoxing Pharmaceutical Company Inc, Arrowhead Pharmaceuticals Inc, AstraZeneca Plc, Athersys Inc, Auris Medical Holding AG, Bial - Portela & Ca SA, Biophytis SA, BioRestorative Therapies Inc, Biozeus, Boehringer Ingelheim GmbH, Braasch Biotech LLC, C3J Therapeutics Inc, Callitas Therapeutics Inc, Carmot Therapeutics Inc, Celon Pharma SA, Chong Kun Dang Pharmaceutical Corp, CohBar Inc, CoMentis Inc, Corcept Therapeutics Inc, Daiichi Sankyo Co Ltd, DiscoveryBiomed Inc, Eisai Co Ltd, Eli Lilly and Co, Eternygen GmbH, Evotec AG, FibroGen Inc, Genmedica Therapeutics SL, Gila Therapeutics Inc, Gilead Sciences Inc, GlaxoSmithKline Plc, Glucox Biotech AB, HanAll Biopharma Co Ltd, Hanmi Pharmaceuticals Co Ltd, Hyundai Pharmaceutical Co Ltd, Immungenetics AG, Intarcia Therapeutics Inc, Ionis Pharmaceuticals Inc, Johnson & Johnson, Juno Therapeutics Inc, Kissei Pharmaceutical Co Ltd, Lead Discovery Center GmbH, Leading BioSciences Inc, Magnus Life Ltd, MedImmune LLC, Merck & Co Inc, Naia Ltd, NeuroNano Pharma Inc, NGM Biopharmaceuticals Inc, NIBEC, Nordic Bioscience A/S, Novartis AG, Novo Nordisk AS, ObeTherapy Biotechnology, Omeros Corp, OPKO Biologics Ltd, OPKO Health Inc, Oramed Pharmaceuticals Inc, Palatin Technologies Inc, Peptron Inc, Pfizer Inc, PharmaIN Corp, Poxel SA, ProMetic Life Sciences Inc, Regeneron Pharmaceuticals Inc, Renova Therapeutics Inc, Reviva Pharmaceuticals Inc, Saniona AB, Sanofi, Seres Therapeutics Inc, Shionogi & Co Ltd, Sinil Pharmaceutical Co Ltd, SJT Molecular Research SL, Takeda Pharmaceutical Co Ltd, Toray Industries Inc, Vicore Pharma AB, Viking Therapeutics Inc, Vivus Inc, WhanIn Pharmaceutical Co Ltd, XL-protein GmbH, Yuhan Corp, Yuyu Pharma Inc, Zafgen Inc & Zealand Pharma AS.
Make inquiry before purchase @ https://www.htfmarketreport.com/enquiry-before-buy/1197577-obesity-pipeline-review-4
The guide features dormant and discontinued projects and covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase I, Preclinical and Discovery stages are 1, 1, 9 and 1 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 3 and 1 molecules, respectively.
Obesity - Pipeline pipeline guide helps in identifying and tracking emerging and major players moves in the market and their portfolios, enhances decision making capabilities and helps to create effective marketing strategies to gain competitive advantage in health care and pharmaceuticals industry. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. The data and information sourced from the databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the latest key developments are captured on a real time basis.
Buy this research report @ https://www.htfmarketreport.com/buy-now?format=1&report=1197577
Extracts of Chapters from Obesity - Pipeline Review, H1 2018
Chapter 1 , to describe the definition , overview and Therapeutics Development of Obesity - Pipeline.
Chapter2, to analyze the pipeline overview of companies, Universities/Institutes and the product development under by companies, Universities/Institutes.
Chapter3, Therapeutics Assessment of Obesity - Pipeline by Target, Mechanism of Action, Route of Administration and by Molecule Type.
Chapter4, to display company profile involved in Therapeutics Development.
Chapter5, Drug profile product description, Mechanism of action and R&D Progress of Obesity - Pipeline.
Chapter 6,7, to describe Obesity - Pipeline Appendix, Methodology ,Coverage ,Secondary Research ,Primary Research ,Expert Panel Validation and Contact Us.
Objective of this study
- To provides a snapshot of the global therapeutic landscape of Obesity - Pipeline.
- To reviews pipeline therapeutics for Obesity - Pipeline by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprises, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Obesity - Pipeline therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Obesity - Pipeline therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Obesity - Pipeline
Reasons to buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Obesity - Pipeline.
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Obesity - Pipeline pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Early buyers will receive 10% customization on reports. Read Detailed Index of full Research Study at @ https://www.htfmarketreport.com/reports/1197577-obesity-pipeline-review-4
Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.
About Author:
HTF Market Report is a wholly owned brand of HTF market Intelligence Consulting Private Limited. HTF Market Report global research and market intelligence consulting organization is uniquely positioned to not only identify growth opportunities but to also empower and inspire you to create visionary growth strategies for futures, enabled by our extraordinary depth and breadth of thought leadership, research, tools, events and experience that assist you for making goals into a reality. Our understanding of the interplay between industry convergence, Mega Trends, technologies and market trends provides our clients with new business models and expansion opportunities. We are focused on identifying the “Accurate Forecast” in every industry we cover so our clients can reap the benefits of being early market entrants and can accomplish their “Goals & Objectives”.
Contact US :
Craig Francis (PR & Marketing Manager)
HTF Market Intelligence Consulting Private Limited
Unit No. 429, Parsonage Road Edison, NJ
New Jersey USA – 08837
Phone: +1 (206) 317 1218
sales@htfmarketreport.com
Connect with us at
https://www.linkedin.com/company/13388569/
https://www.facebook.com/htfmarketintelligence/
https://twitter.com/htfmarketreport
https://plus.google.com/u/0/+NidhiBhawsar-SEO_Expert?rel=author
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Obesity - Pipeline Review, H1 With key players Abeome Corp, Adocia SAS, Aegis Therapeutics LLC, Amgen here
News-ID: 1397834 • Views: …
More Releases from HTF Market Intelligence Consulting Pvt. Ltd.
Police Records Management System Market Emerging Player Outperforming: Motorola …
According to HTF Market Intelligence, the global Police Records Management System market is valued at 594.14 USD Million in 2025 with a CAGR of 10.9% from 2025 to 2031.
HTF MI recently introduced Global Police Records Management System Market study with 143+ pages in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status (2025-2031). The market Study is segmented by key regions which is accelerating the…
Sports Shotgun Market to See Sustainable Growth Ahead: Beretta, Armi Perazzi, Fa …
According to HTF Market Intelligence, the global Sports Shotgun market is valued at 265 USD Million in 2025 and estimated to reach revenue of 429 USD Million by 2031, with a CAGR of 5.5% from 2025 to 2031.
HTF MI recently introduced Global Sports Shotgun Market study with 143+ pages in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status (2025-2031). The market Study is segmented…
AI Solutions in Engineering Market May Set a New Growth Story | Dolbey System, G …
According to HTF Market Intelligence, the Global AI Solutions in Engineering market to witness a CAGR of 49.82% during the forecast period (2025-2030). The Latest Released AI Solutions in Engineering Market Research assesses the future growth potential of the AI Solutions in Engineering market and provides information and useful statistics on market structure and size.
This report aims to provide market intelligence and strategic insights to help decision-makers make sound investment…
Livestock Monitoring Market to See Revolutionary Growth: GEA Group, Merck Animal …
According to HTF Market Intelligence, the Global Livestock Monitoring market to witness a CAGR of 15.4% during the forecast period (2025-2030). The Latest Released Livestock Monitoring Market Research assesses the future growth potential of the Livestock Monitoring market and provides information and useful statistics on market structure and size.
This report aims to provide market intelligence and strategic insights to help decision-makers make sound investment decisions and identify potential gaps and…
More Releases for Obesity
Anti-Obesity Drugs Market Grows Rapidly, Driven by Obesity Rates and Therapeutic …
Anti-Obesity Drugs Market valued at USD 5.9 Bn in 2024, growing at 16.5% CAGR to reach USD 20.02 Bn by 2032. Driven by GLP-1 therapies and rising obesity rates.
Anti Obesity Drugs Market Overview:
The anti-obesity drugs market is undergoing significant transformation as awareness about obesity-related health risks rises globally. With growing concern over lifestyle-related disorders, there is an increasing emphasis on medical intervention as a complement to traditional weight management strategies.…
Fuzzle joins The Obesity Society & The Obesity Action Coalition; Promotes Habit- …
Building healthy, sustainable habits for long-term weight management success.
Tampa, FL - March 18, 2025 - Fuzzle, an emerging leader in the wellness landscape, is pleased to announce that it's now a Member of The Obesity Society, as well as the Obesity Action Coalition, marking a new milestone in the company's mission to transform how individuals approach weight loss.
Image: https://www.globalnewslines.com/uploads/2025/03/77da787ae98a633847c70fc22e2943c7.jpg
Fuzzle supports individuals in their wellness journey through non-invasive, drug-free strategies. With…
Pediatric Obesity Management Market - Healthy Habits for Life: Advancing Pediatr …
Newark, New Castle, USA: The "Pediatric Obesity Management Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Pediatric Obesity Management Market: https://www.growthplusreports.com/report/pediatric-obesity-management-market/8930
This latest report researches the industry structure,…
Anti-Obesity Drugs Market - From Obesity to Vitality: Leading the Way in Effecti …
Newark, New Castle, USA - new report, titled Anti-Obesity Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Anti-Obesity Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Anti-Obesity Drugs market. The report offers an overview of the market, which…
Increasing Prevalence of Obesity Driving Obesity/Bariatric Surgery Devices Marke …
The global obesity/bariatric surgery devices market revenue stood at $1.4 billion in 2016, and it is expected to rise to $2.8 billion by 2023. Furthermore, the market will progress at a CAGR of 9.9% from 2017 to 2023 (forecast period), as per the estimates of the market research company, P&S Intelligence. The major growth drivers of the market are the rising incidence of obesity, owing to unhealthy diets and lifestyle…
Fast Food and Obesity
Most of the fast food in the market contains a large quantity of sugar, #carbs and fats with a lesser quantity of vitamins and minerals. The unhealthy food ingredients in the fast food are further increased with increased portion size. The person will still consume the whole meal regardless of being completely full. People cannot stop ravishing on fast food because it is available for low cost and in close…
